**Eye Melanoma Market Report 2025 – Opportunities and Growth Drivers**

 What is the current size and annual growth rate of the eye melanoma market?

The eye melanoma market size has grown strongly in recent years. It will grow from $9.1 billion in 2024 to $9.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased awareness and early detection, aging population and sun exposure, rise in skin cancer incidence, development of targeted therapies, patient advocacy and support programs.

The eye melanoma market size is expected to see strong growth in the next few years. It will grow to $13.77 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to continued public health initiatives, research in genetic and molecular profiling, global aging population trends. Major trends in the forecast period include integration of artificial intelligence (ai), emergence of targeted therapies, focus on rare disease drug development, patient-centric drug approval processes, advancements in diagnostic imaging, advancements in treatment modalities, technological innovations in imaging.



Get Your Free Sample of The Global Eye Melanoma Market Report:
Eye Melanoma Market Report 2025

What key drivers have fueled the eye melanoma market’s development over the years?

The increasing prevalence of eye cancer is expected to propel the growth of the eye melanoma market going forward. Eye cancer refers to the development of abnormal and uncontrolled cell growth within the eye's structures. The growing recognition and effective management of early cases are creating a heightened need for specialized therapies and interventions, propelled by improved detection methods, increased awareness, and advancements in treatment options. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of eye and orbital cancer cases increased to 3,490 in 2023, reflecting a growth of 5.12% from 3,320 in 2021. Therefore, the increasing prevalence of eye cancer will drive the growth of the eye melanoma market.

What is the segmentation for the eye melanoma market?
The eye melanoma market covered in this report is segmented –

1) By Site: Uvea, Sclera, Retina
2) By Diagnosis: Imaging, Biopsy, Eye Exam
3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment
4) By End User: Hospitals And Clinics, Academic Institutes

Subsegments:
1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma
2) By Sclera: Scleral Melanoma
3) By Retina: Retinal Melanoma

Order your report now for swift delivery
Eye Melanoma Market Report 2025

Who are the most influential companies in the eye melanoma market?

Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.

What are the top industry trends projected to impact the eye melanoma market?

Major companies operating in the eye melanoma treatment sector are focused on developing innovative and specialized treatments, such as immunotherapies and targeted therapies, to enhance patient outcomes and quality of life. Immunotherapies and targeted therapies are novel treatment modalities that have recently begun to enter the oncology field. For instance, in January 2022, Immunocore Ltd., a UK-based biopharmaceutical company that focuses on research and development of biological drugs using soluble T-cell receptor technology, received approval from the U.S. Food and Drug Administration (FDA) for Kimmtrak (tebentafusp-tabn), a T-cell receptor therapeutic, which is the first therapy for individuals with unresectable or metastatic uveal melanoma (mUM). Kimmtrak is an immunotherapy that targets a specific protein called gp100, which is present on the surface of uveal melanoma (UM) cells. It activates the patient's immune system to eliminate melanoma by engaging specialized immune cells through engineered T-cell receptors, offering a precision-driven approach to cancer treatment.

What are the major regional insights for the eye melanoma market, and which region holds the top position?

North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Does The Eye Melanoma Market Report 2025 Offer?

The eye melanoma market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Eye melanoma is a type of cancer that develops in the melanocytes, the cells that produce melanin within the eye. It occurs in different parts of the eye, including the uvea, the iris, and the choroid. Eye melanoma is the most common primary intraocular cancer in adults and can cause vision problems, changes in eye color, and other symptoms depending on its location and size.

Purchase the exclusive report now to unlock valuable market insights:
Eye Melanoma Market Report 2025

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: The Road Ahead for the Silicon metal size Market: Key Growth Trends and Opportunities to Watch - Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports - By The Business Research Company
Global Market Model: Global Market Intelligence Database